News

Vaccine exports get a shot in the arm from global drug demand. Pune’s Serum Institute of India (SII) has shipped 30 million doses of the AstraZeneca-Oxford vaccine to 20 countries. Bharat Biotech is all set to start exports to...

Ocugen, Inc., a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, and Bharat Biotech, a global leader in vaccine innovation, announced they have entered into a...

Iran began its Covid-19 vaccination campaign on Tuesday using Russia's Sputnik V jab to fight the Middle East's deadliest outbreak of the illness. The first doses were given to doctors and nurses at Imam Khomeini hospital in the capital Tehran,...

Business intelligence platform Suppleye has launched a free tool to help pharmaceutical professionals stay on top of critical supply market news. Suppleye provides users with an intelligent resource to monitor key market news within the pharmaceutical sector and track sentiment....

Vir Biotechnology, Inc. announced the publication of new research characterizing a novel site of vulnerability on the SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) spike protein – specifically the N-terminal domain (NTD). The study findings were made available online on...

Cytiva launches the “Exosome Challenge,” an industry challenge to overcome hurdles in exosome production and manufacturing. The challenge will focus on the standard workflow, in three focus areas: Cell engineering: Developing innovative technologies to engineer cell lines that can produce...

Avid Bioservices, Inc. and Humanigen, Inc. announced that they have entered into a manufacturing services agreement to expand production capacity for lenzilumab™, Humanigen’s therapeutic candidate in development for COVID-19. Lenzilumab is an anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal...